Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593–606, Sep/Oct 2018, DOI: 10.1002/pst.1873

ASA Special Interest Group on Statistics and Pharmacometrics/ASA Special Interest Group on Statistics and Pharmacometrics (SIG SxP)

doi:10.1002/pst.1940

Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593–606, Sep/Oct 2018, DOI: 10.1002/pst.1873

ASA Special Interest Group on Statistics and Pharmacometrics/ASA Special Interest Group on Statistics and Pharmacometrics (SIG SxP)

Pharmaceutical Sciences

Idorsia Pharmaceuticals Ltd.
Free University of Berlin
University of Potsdam
Uppsala University
Johnson & Johnson
Metrum Research Group
UMR 1137
Regeneron Pharmaceuticals, Inc.

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	278-281
Number of pages	4
Journal	Pharmaceutical Statistics
Volume	18
Issue number	3
DOIs	https://doi.org/10.1002/pst.1940
State	Published - May 1 2019

Access to Document

10.1002/pst.1940

Cite this

ASA Special Interest Group on Statistics and Pharmacometrics/ASA Special Interest Group on Statistics and Pharmacometrics (SIG SxP) (2019). Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593–606, Sep/Oct 2018, DOI: 10.1002/pst.1873. Pharmaceutical Statistics, 18(3), 278-281. https://doi.org/10.1002/pst.1940

ASA Special Interest Group on Statistics and Pharmacometrics/ASA Special Interest Group on Statistics and Pharmacometrics (SIG SxP). / Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593–606, Sep/Oct 2018, DOI : 10.1002/pst.1873. In: Pharmaceutical Statistics. 2019 ; Vol. 18, No. 3. pp. 278-281.

@article{d19e3d3697174e47afbb73fb65b3a204,

title = "Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593–606, Sep/Oct 2018, DOI: 10.1002/pst.1873",

author = "\{ASA Special Interest Group on Statistics and Pharmacometrics/ASA Special Interest Group on Statistics and Pharmacometrics (SIG SxP)\} and Andreas Krause and Charlotte Kloft and Wilhelm Huisinga and Mats Karlsson and Jos{\'e} Pinheiro and Robert Bies and James Rogers and France Mentr{\'e} and Musser, \{Bret J.\}",

year = "2019",

month = may,

day = "1",

doi = "10.1002/pst.1940",

language = "English",

volume = "18",

pages = "278--281",

journal = "Pharmaceutical Statistics",

issn = "1539-1604",

publisher = "John Wiley and Sons Ltd",

number = "3",

}

ASA Special Interest Group on Statistics and Pharmacometrics/ASA Special Interest Group on Statistics and Pharmacometrics (SIG SxP) 2019, 'Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593–606, Sep/Oct 2018, DOI: 10.1002/pst.1873', Pharmaceutical Statistics, vol. 18, no. 3, pp. 278-281. https://doi.org/10.1002/pst.1940

Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593–606, Sep/Oct 2018, DOI: 10.1002/pst.1873. / ASA Special Interest Group on Statistics and Pharmacometrics/ASA Special Interest Group on Statistics and Pharmacometrics (SIG SxP).
In: Pharmaceutical Statistics, Vol. 18, No. 3, 01.05.2019, p. 278-281.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593–606, Sep/Oct 2018, DOI

T2 - 10.1002/pst.1873

AU - ASA Special Interest Group on Statistics and Pharmacometrics/ASA Special Interest Group on Statistics and Pharmacometrics (SIG SxP)

AU - Krause, Andreas

AU - Kloft, Charlotte

AU - Huisinga, Wilhelm

AU - Karlsson, Mats

AU - Pinheiro, José

AU - Bies, Robert

AU - Rogers, James

AU - Mentré, France

AU - Musser, Bret J.

PY - 2019/5/1

Y1 - 2019/5/1

UR - https://www.scopus.com/pages/publications/85063692417

U2 - 10.1002/pst.1940

DO - 10.1002/pst.1940

M3 - Letter

C2 - 30932340

AN - SCOPUS:85063692417

SN - 1539-1604

VL - 18

SP - 278

EP - 281

JO - Pharmaceutical Statistics

JF - Pharmaceutical Statistics

IS - 3

ER -

ASA Special Interest Group on Statistics and Pharmacometrics/ASA Special Interest Group on Statistics and Pharmacometrics (SIG SxP). Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593–606, Sep/Oct 2018, DOI: 10.1002/pst.1873. Pharmaceutical Statistics. 2019 May 1;18(3):278-281. doi: 10.1002/pst.1940

Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593–606, Sep/Oct 2018, DOI: 10.1002/pst.1873

Access to Document

Other files and links

Fingerprint

Cite this